A phase II study of platinum and etoposide chemotherapy, durvalumab with thoracic radiotherapy in the first line treatment of patients with extensive-stage small-cell lung cancer
Chemotherapy and Immunotherapy in extensive stage small cell lung cancer with thoracic radiotherapy